Agility Life Sciences forge Strategic Partnership with SolitekVicky Coghlan2023-04-03T14:26:02+01:00April 3rd, 2023|Article, Headline Article, MediCity Nottingham, News|
Alveron Pharma Commences Clinical Trial of New Intracranial Haemorrhage DrugVicky Coghlan2023-04-03T13:59:35+01:00March 31st, 2023|BioCity Nottingham, News|
Myconeos Innovate UK Smart Grant SuccessVicky Coghlan2023-03-28T14:48:14+01:00March 28th, 2023|BioCity Nottingham, News|
New Platform Set to Accelerate Early-Stage Targeted Protein Degradation ProgrammesVicky Coghlan2023-06-27T09:55:06+01:00March 7th, 2023|Article, BioCity Nottingham, News|
£20m Series A Funding For Two Pioneer Group Accelerator Programme GraduatesVicky Coghlan2023-03-09T15:14:09+00:00February 15th, 2023|Accelerator, Headline Article, News|
Pioneer Group Announce Lead Investment in Selentus ScienceVicky Coghlan2023-02-10T10:37:09+00:00February 7th, 2023|BioCity Nottingham, Investment, News|